Hot Investor Mandate: Investment Arm of Major Health System Makes Strategic Investments in Early-Stage Medtech, Diagnostic, and Digital Health Technologies

8 Nov

The venture capital arm of a major health system looks to invest between $500K – $5M, in Seed, Series A and Series B rounds. The firm is looking to invest in technologies that can be leveraged by a large healthcare system. The group is currently looking for opportunities throughout the United States.

The firm is looking to invest in companies with strong ROI potential that also are strategically aligned with the group’s parent healthcare system. The group is interested in companies meeting this criteria operation in the digital health, medical devices and diagnostics. The group is open to investing in companies that are pre-revenue, including those with a product still in development or in clinical trials. The firm does not invest in therapeutics or Class III medical devices.

The firm is looking for companies with experienced management teams and generally seeks board representation following investment. The group is also interested in forming joint-ventures or co-development programs when relevant and looks to leverage its connection to the firm to aid companies as well.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: